IFP Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7K | Sell |
246
-45
| -15% | -$347 | ﹤0.01% | 4020 |
|
|
2025
Q4 | $2.57K | Buy |
291
+146
| +101% | +$804 | ﹤0.01% | 3739 |
|
|
2025
Q3 | $724 | Buy |
+145
| New | +$671 | ﹤0.01% | 4057 |
|
|
2025
Q2 | – | Sell |
-10
| Closed | -$44 | – | 4494 |
|
|
2025
Q1 | $46 | Hold |
10
| – | – | ﹤0.01% | 4038 |
|
|
2024
Q4 | $48 | Buy |
+10
| New | +$48 | ﹤0.01% | 4274 |
|
|
2023
Q4 | – | Sell |
-295
| Closed | -$1.27K | – | 3360 |
|
|
2023
Q3 | $1.27K | Hold |
295
| – | – | ﹤0.01% | 2944 |
|
|
2023
Q2 | $1.94K | Hold |
295
| – | – | ﹤0.01% | 2887 |
|
|
2023
Q1 | $5.22K | Hold |
295
| – | – | ﹤0.01% | 2547 |
|
|
2022
Q4 | $5K | Hold |
295
| – | – | ﹤0.01% | 3823 |
|
|
2022
Q3 | $5K | Hold |
295
| – | – | ﹤0.01% | 4066 |
|
|
2022
Q2 | $5K | Hold |
295
| – | – | ﹤0.01% | 3833 |
|
|
2022
Q1 | $5K | Hold |
295
| – | – | ﹤0.01% | 3833 |
|
|
2021
Q4 | $5K | Hold |
295
| – | – | ﹤0.01% | 2518 |
|
|
2021
Q3 | $5K | Hold |
295
| – | – | ﹤0.01% | 2579 |
|
|
2021
Q2 | $6K | Hold |
295
| – | – | ﹤0.01% | 2426 |
|
|
2021
Q1 | $4K | Hold |
295
| – | – | ﹤0.01% | 2504 |
|
|
2020
Q4 | $4K | Buy |
+295
| New | +$3.55K | ﹤0.01% | 2438 |
|
|
2019
Q1 | – | Sell |
-1,425
| Closed | -$37K | – | 3446 |
|
|
2018
Q4 | $37K | Buy |
1,425
+225
| +19% | +$5.29K | ﹤0.01% | 1786 |
|
|
2018
Q3 | $28K | Buy |
+1,200
| New | +$24.5K | ﹤0.01% | 2263 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$18K | – | 4114 |
|
|
2017
Q3 | $18K | Buy |
+1,000
| New | +$16.7K | ﹤0.01% | 2678 |
|
Other funds holding VNDA
ACM
VCM
